AUA2023: Refractory Overactive Bladder: How To Select 3rd Line Therapies and Optimize Outcomes

AUA2023: Refractory Overactive Bladder: How To Select 3rd Line Therapies and Optimize Outcomes CME Available: https://auau.auanet.org/node/38287 CME Expiration Date: May, 2024 ACKNOWLEDGEMENTS Independent educational grant support provided by: Astellas Urovant Sciences, Inc.

Om Podcasten

The AUAUniversity podcast is an official podcast of the American Urological Association. More information can be found at https://auau.auanet.org